Our mission is to promote xenotransplantation as a safe, ethical, and effective therapeutic modality
Dec.19 (Fri) – 20 (Sat), 2025
Chairman: Yi Wang, MD, PhD
Registration Call for AbstractsAXA 2025 inaugurates the first congress dedicated exclusively to xenotransplantation in Asia,
gathering the field’s leading scientists to share groundbreaking advances and expert insights. At this time of unprecedented progress, it is the essential opportunity to remain at the forefront.
Will you be there?
The Asian Xenotransplantation Association (AXA) was established with the mission of advancing xenotransplantation science, fostering regional collaboration, and promoting ethical practices to address the critical organ shortage crisis in Asia.
AXA’s foundational goals are closely aligned with the urgent need for innovative medical solutions and structured cooperation across the region. The Association is dedicated to creating a sustainable platform for scientific exchange, supporting technology transfer, and developing harmonized guidelines to ensure the highest standards of research integrity, clinical safety, and biological security. Through these efforts, AXA aims to significantly contribute to public health improvement and human welfare throughout Asia.
The AXA’s mission is to advance xenotransplantation as a safe, ethical, and accessible therapeutic solution for Asia by:
We are delighted to welcome you to the Asian Xenotransplantation Association (AXA) — a dynamic and growing community dedicated to advancing the field of xenotransplantation across Asia and worldwide.
As xenotransplantation enters an exciting new era marked by significant clinical progress, the establishment of AXA represents a pivotal step forward in strengthening regional collaboration and scientific exchange. Our association brings together leading researchers, clinicians, and experts from across Asia and beyond—all of whom are at the forefront of innovation in xenotransplantation science.
Through AXA, members will have valuable opportunities to network with peers, learn from pioneering experts, and engage in meaningful discussions on the latest breakthroughs and future directions in the field. We are committed to creating an inclusive, enriching, and impactful platform that supports professional growth and fosters international partnerships.
Join us as we work together to shape the future of xenotransplantation—promoting innovation, improving patient care, and building a collaborative network that spans the globe.
We look forward to welcoming you and advancing this vital field together.
Yi Wang, MD, PhD
AXA President
Hidetaka Hara, MD, PhD
AXA Secretary General